These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 20861110)

  • 1. Gastro-oesophageal reflux. Physiological or pathological?
    Marchetti F; Tornese G; Ventura A
    BMJ; 2010 Sep; 341():c5155. PubMed ID: 20861110
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proton pump inhibitors in gastro-oesophageal reflux disease: what is the further step?].
    Simon M; Zerbib F
    Presse Med; 2013; 42(7-8):1081-4. PubMed ID: 23079391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of heartburn not responding to proton pump inhibitors.
    Fass R; Sifrim D
    Gut; 2009 Feb; 58(2):295-309. PubMed ID: 19136523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent reflux symptoms in the proton pump inhibitor era: the changing face of gastroesophageal reflux disease.
    Dellon ES; Shaheen NJ
    Gastroenterology; 2010 Jul; 139(1):7-13.e3. PubMed ID: 20493864
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
    Sweis R; Anggiansah A; Wong T
    Clin Gastroenterol Hepatol; 2010 Mar; 8(3):313. PubMed ID: 19788931
    [No Abstract]   [Full Text] [Related]  

  • 6. Correct use of proton pump inhibitors for gastro-oesophageal reflux disease.
    Hatlebakk JG; Emken BE; Glazkov V; Hoff DA; Hausken T
    Tidsskr Nor Laegeforen; 2013 Jan; 133(1):43-6. PubMed ID: 23306993
    [No Abstract]   [Full Text] [Related]  

  • 7. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
    Pohl D; Tutuian R
    Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Night-time intra-oesophageal bile and acid: a comparison between gastro-oesophageal reflux disease patients who failed and those who were treated successfully with a proton pump inhibitor.
    Hershcovici T; Jha LK; Cui H; Powers J; Fass R
    Aliment Pharmacol Ther; 2011 Apr; 33(7):837-44. PubMed ID: 21261670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review article: how valuable are proton-pump inhibitors in establishing a diagnosis of gastro-oesophageal reflux disease?
    Vakil N
    Aliment Pharmacol Ther; 2005 Aug; 22 Suppl 1():64-9. PubMed ID: 16042661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gastro-oesophageal reflux disease].
    Labenz J; Leodolter A
    MMW Fortschr Med; 2009 Apr; 151(14):40-4; quiz 45. PubMed ID: 19504840
    [No Abstract]   [Full Text] [Related]  

  • 11. The evolution of proton pump inhibitors for the treatment of gastroesophageal reflux disease.
    Friedlander EA; Pallentino J; Miller SK; VanBeuge SS
    J Am Acad Nurse Pract; 2010 Dec; 22(12):674-83. PubMed ID: 21129076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extra-oesophageal reflux: state of the knowledge base.
    Ah-See K; Wilson J
    Clin Otolaryngol; 2012 Feb; 37(1):9-16. PubMed ID: 22433134
    [No Abstract]   [Full Text] [Related]  

  • 13. Sleep disturbances associated with gastro-oesophageal reflux disease: prevalence and impact of treatment in French primary care patients.
    Cadiot G; Delaage PH; Fabry C; Soufflet C; Barthélemy P
    Dig Liver Dis; 2011 Oct; 43(10):784-7. PubMed ID: 21752736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor.
    Juul-Hansen P; Rydning A
    Aliment Pharmacol Ther; 2009 Jan; 29(2):207-12. PubMed ID: 19006541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gastro-esophageal reflux through gastric antisecretory drugs].
    Jian R
    Gastroenterol Clin Biol; 2009; 33(8-9):614-24. PubMed ID: 19674856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastro-oesophageal reflux disease--impact of guidelines on GP management.
    Kirby CN; Piterman L; Nelson MR; Dent J
    Aust Fam Physician; 2008; 37(1-2):73-7. PubMed ID: 18239758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastro-oesophageal reflux disease.
    Sifrim D; Lundell L; Zerbib F
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):757-8. PubMed ID: 21126690
    [No Abstract]   [Full Text] [Related]  

  • 19. Review article: gastro-oesophageal reflux disease and psychological comorbidity.
    Mizyed I; Fass SS; Fass R
    Aliment Pharmacol Ther; 2009 Feb; 29(4):351-8. PubMed ID: 19035971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastroesophageal reflux disease: endoscopy, duration of treatment, and choice of PPI.
    Greenspan NR
    Med Health R I; 2011 Apr; 94(4):92-4. PubMed ID: 21667598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.